Brief: Integra Lifesciences Q3 Adjusted EPS USD 0.76 Vs. IBES Estimate USD 0.78
25/10/2023 11:00
Oct 25 (Reuters) - Integra Lifesciences Q3 revenue USD 382.4 million vs. IBES estimate USD 387.1 million. * Q3 adjusted gross margin 64.6% * Q3 EPS USD 0.24 * Q3 adjusted net income USD 60.5 million * Q3 adjusted EBITDA USD 88.1 million
Recent news on Integra LifeSciences Holdings
See all newsIntegra LifeSciences Holdings Corporation reports results for the quarter ended September 30 - Earnings Summary
Integra Lifesciences Q3 revenue slightly misses estimates on flood damage
Brief: Integra Lifesciences - Enters Amended And Restated Credit Agreement On Oct 19, 2026 - SEC Filing
Brief: Integra Announces Completion Of Refinancing Transactions
Brief: Integra Announces Pricing Of Senior Secured Notes